Cited by 512Nanoparticle-Based Drug DeliveryNanoplatforms for cancer theranosticsDendrimers and Hyperbranched Polymers

The DOI matches its Crossref record; 527 of the 529 references it cites were found in a registry or an index.

The Use of Alternative Strategies for Enhanced Nanoparticle Delivery to Solid Tumors

Open access

Izci, Mukaddes, Maksoudian, Christy, Manshian, Bella B., Soenen, Stefaan J.·2021·Chemical Reviews

DOI 10.1021/acs.chemrev.0c00779PMC PMC7883342

Open this paper in CoChat — free account Open PDF

Abstract

Abstract Nanomaterial (NM) delivery to solid tumors has been the focus of intense research for over a decade. Classically, scientists have tried to improve NM delivery by employing passive or active targeting strategies, making use of the so-called enhanced permeability and retention (EPR) effect. This phenomenon is made possible due to the leaky tumor vasculature through which NMs can leave the bloodstream, traverse through the gaps in the endothelial lining of the vessels, and enter the tumor. Recent studies have shown that despite many efforts to employ the EPR effect, this process remains very poor. Furthermore, the role of the EPR effect has been called into question, where it has been suggested that NMs enter the tumor via active mechanisms and not through the endothelial gaps. In this review, we provide a short overview of the EPR and mechanisms to enhance it, after which we focus on alternative delivery strategies that do not solely rely on EPR in itself but can offer interesting pharmacological, physical, and biological solutions for enhanced delivery. We discuss the strengths and shortcomings of these different strategies and suggest combinatorial approaches as the ideal path forward.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1021/acs.chemrev.0c00779

Cites

527 of 527 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Items 401–527 of 527

Multiscale Measurements Distinguish Cellular and Interstitial Hindrances to Diffusion In Vivo
Chauhan, V. P., Lanning, R. M., Diop-Frimpong, B., Mok, W., Brown, E. B., Padera, T. P., Boucher, Y., & Jain, R. K. (2009) · Biophysical Journal · doi:10.1016/j.bpj.2009.03.064 · Cited by 78
Combined use of percutaneous ethanol injection and radiofrequency ablation for the effective treatment of hepatocelluar carcinoma
Kurokohchi, K., Watanabe, S., Masaki, T., Hosomi, N., Funaki, T., Arima, K., Yoshida, S., Miyauchi, Y., & Kuriyama, S. (2002) · International Journal of Oncology · doi:10.3892/ijo.21.4.841 · Cited by 78
Peptide-conjugated polymeric micellar nanoparticles for Dual SPECT and optical imaging of EphB4 receptors in prostate cancer xenografts
Zhang, R., Xiong, C., Huang, M. L., Zhou, M., Huang, Q., Wen, X., Liang, D., & Li, C. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.04.070 · Cited by 78
Tumour hyperthermia and ablation in rats using a clinical MR‐HIFU system equipped with a dedicated small animal set‐up
Hijnen, N. M., Heijman, E., Köhler, M. O., Ylihautala, M., Ehnholm, G. J., Simonetti, A. W., & Grüll, H. (2012) · International Journal of Hyperthermia · doi:10.3109/02656736.2011.648137 · Cited by 78
Investigating the effect of tumor vascularization on magnetic targeting in vivo using retrospective design of experiment
Mei, K., Bai, J., Lorrio, S., Wang, J. T.-W., & Al‐Jamal, K. T. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.08.030 · Cited by 77
Two‐Photon In Vivo Imaging with Porous Silicon Nanoparticles
Kim, D., Kang, J., Wang, T., Ryu, H. G., Zuidema, J. M., Joo, J., Kim, M., Huh, Y., Jung, J., Ahn, K. H., et al. (2017) · Advanced Materials · doi:10.1002/adma.201703309 · Cited by 77
Nanoparticles for multimodal antivascular therapeutics: Dual drug release, photothermal and photodynamic therapy
Paris, J. L., Villaverde, G., Gómez‐Graña, S., & Vallet‐Regí, M. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.11.004 · Cited by 77
VEGFR targeting leads to significantly enhanced tumor uptake of nanographene oxide in vivo
Shi, S., Yang, K., Hong, H., Chen, F., Valdovinos, H. F., Goel, S., Barnhart, T. E., Liu, Z., & Cai, W. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.10.061 · Cited by 76
Imaging-guided high-efficient photoacoustic tumor therapy with targeting gold nanorods
Zhong, J., Wen, L., Yang, S., Xiang, L., Chen, Q., & Xing, D. (2015) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2015.04.002 · Cited by 75
Targeted salinomycin delivery with EGFR and CD133 aptamers based dual-ligand lipid-polymer nanoparticles to both osteosarcoma cells and cancer stem cells
Chen, F., Zeng, Y., Qi, X., Chen, Y., Ge, Z., Jiang, Z., Zhang, X., Dong, Y., Chen, H., & Yu, Z. (2018) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2018.05.015 · Cited by 75
Prediction of anti-cancer nanotherapy efficacy by imaging
Miller, M. A., Arlauckas, S., & Weissleder, R. (2017) · Nanotheranostics · doi:10.7150/ntno.20564 · Cited by 74
Photofrin and light induces microtubule depolymerization in cultured human endothelial cells.
Sporn, L. A., & Foster, T. H. (1992) · PubMed · Cited by 73
Bioactive Polyelectrolyte Multilayers: Hyaluronic Acid Mediated B Lymphocyte Adhesion
Vasconcellos, F. C., Swiston, A. J., Beppu, M. M., Cohen, R. E., & Rubner, M. F. (2010) · Biomacromolecules · doi:10.1021/bm100570r · Cited by 73
The multifaceted role of extracellular vesicles in metastasis: Priming the soil for seeding
Pultz, B. D. A., da Luz, F. A. C., Faria, S. S., de Souza, L. P. M., Tavares, P. C. B., Alonso‐Goulart, V., Fontes, W., Goulart, L. R., & Silva, M. J. B. (2017) · International Journal of Cancer · doi:10.1002/ijc.30595 · Cited by 73
Can dual-ligand targeting enhance cellular uptake of nanoparticles?
Xia, Q., Ding, H., & Ma, Y. (2017) · Nanoscale · doi:10.1039/c7nr01020f · Cited by 73
MR/SPECT Imaging Guided Photothermal Therapy of Tumor-Targeting Fe@Fe3O4 Nanoparticles in Vivo with Low Mononuclear Phagocyte Uptake
Wang, J., Zhao, H., Zhou, Z., Zhou, P., Yan, Y., Wang, M., Yang, H., Zhang, Y., & Yang, S. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b04639 · Cited by 72
A tumor-penetrating peptide enhances circulation-independent targeting of peritoneal carcinomatosis
Sugahara, K. N., Scodeller, P., Braun, G. B., de Mendoza, T. H., Yamazaki, C. M., Kluger, M. D., Kitayama, J., Alvarez, E. A., Howell, S. B., Teesalu, T., et al. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.06.009 · Cited by 71
Selective eradication of tumor vascular pericytes by peptide-conjugated nanoparticles for antiangiogenic therapy of melanoma lung metastasis
Guan, Y., Luan, X., Xu, J., Liu, Y., Lu, Q., Wang, C., Liu, H.-J., Gao, Y., Chen, H., & Fang, C. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.12.027 · Cited by 71
Factors associated with the performance of carrier erythrocytes obtained by hypotonic dialysis
Millán, C. G., Castañeda, A. Z., Marinero, M. L. S., & Lanao, J. M. (2004) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2004.06.004 · Cited by 71
Nanomedicinal products: a survey on specific toxicity and side effects
Brand, W., Noorlander, C. W., Giannakou, C., de Jong, W., Kooi, M., Park, M. V. D. Z., Vandebriel, R. J., Bosselaers, I. E. M., Scholl, J. H. G., & Geertsma, R. E. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s139687 · Cited by 71
Cell surface negativity and the binding of positively charged particles
Weiss, L., & Zeigel, R. F. (1971) · Journal of Cellular Physiology · doi:10.1002/jcp.1040770208 · Cited by 70
High-content imaging and gene expression analysis to study cell–nanomaterial interactions: The effect of surface hydrophobicity
Manshian, B. B., Moyano, D. F., Corthout, N., Munck, S., Himmelreich, U., Rotello, V. M., & Soenen, S. J. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.08.031 · Cited by 69
Self-citation
Synthesis and evaluation of multivalent M2pep peptides for targeting alternatively activated M2 macrophages
Ngambenjawong, C., Cieslewicz, M., Schellinger, J. G., & Pun, S. H. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.12.057 · Cited by 69
Magnetic Drug Targeting Reduces the Chemotherapeutic Burden on Circulating Leukocytes
Janko, C., Dürr, S., Munoz, L. E., Lyer, S., Chaurio, R. A., Tietze, R., von Löhneysen, S., Schorn, C., i, M. H., & Alexiou, C. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14047341 · Cited by 68
Challenging paradigms in tumour drug delivery
(2020) · Nature Materials · doi:10.1038/s41563-020-0676-x · Cited by 68
Conjugation of pH-responsive nanoparticles to neural stem cells improves intratumoral therapy
Mooney, R., Weng, Y., Garcia, E. P., Bhojane, S., Smith‐Powell, L., Kim, S. U., Annala, A. J., Aboody, K. S., & Berlin, J. M. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.06.015 · Cited by 66
High Resolution Characterization of Engineered Nanomaterial Dispersions in Complex Media Using Tunable Resistive Pulse Sensing Technology
Pal, A. K., Aalaei, I., Gadde, S., Gaines, P. C. W., Schmidt, D. F., Demokritou, P., & Bello, D. (2014) · ACS Nano · doi:10.1021/nn502219q · Cited by 66
Synergetic Combinations of Dual‐Targeting Ligands for Enhanced In Vitro and In Vivo Tumor Targeting
Liu, Y., Hui, Y., Ran, R., Yang, G., Wibowo, D., Wang, H., Middelberg, A. P. J., & Zhao, C. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201800106 · Cited by 66
Toxicological assessment of nanoparticle interactions with the pulmonary system
Osman, N., Sexton, D. W., & Saleem, I. Y. (2019) · Nanotoxicology · doi:10.1080/17435390.2019.1661043 · Cited by 65
Triple-Modal Imaging of Magnetically-Targeted Nanocapsules in Solid Tumours In Vivo
Bai, J., Wang, J. T.-W., Rubio, N., Protti, A., Heidari, H., El-Gogary, R. I., Southern, P., Al-Jamal, W. T., Sosabowski, J. K., Shah, A. M., et al. (2015) · Theranostics · doi:10.7150/thno.11918 · Cited by 64
Erythrocyte Membrane-Wrapped pH Sensitive Polymeric Nanoparticles for Non-Small Cell Lung Cancer Therapy
Gao, L., Wang, H., Nan, L., Peng, T., Sun, L., Zhou, J., Xiao, Y., Wang, J., Sun, J., Lu, W., et al. (2017) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.7b00428 · Cited by 64
Biodistribution of indocyanine green-loaded nanoparticles with surface modifications of PEG and folic acid
Ma, Y., Sadoqi, M., & Shao, J. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.06.007 · Cited by 63
An MRI-based classification scheme to predict passive access of 5 to 50-nm large nanoparticles to tumors
Karageorgis, A., Dufort, S., Sancey, L., Henry, M., Hirsjärvi, S., Passirani, C., Benoît, J., Gravier, J., Texier, I., Montigon, O., et al. (2016) · Scientific Reports · doi:10.1038/srep21417 · Cited by 63
Polymeric nanoparticles conjugate a novel heptapeptide as an epidermal growth factor receptor-active targeting ligand for doxorubicin
Lin, L., & Liu (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s32830 · Cited by 62
Cell penetrating peptides improve tumor delivery of cargos through neuropilin-1-dependent extravasation
Kadonosono, T., Yamano, A., Goto, T., tsubaki, T., Niibori, M., Kuchimaru, T., & Kizaka‐Kondoh, S. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.01.011 · Cited by 62
Superior Intratumoral Penetration of Paclitaxel Nanodots Strengthens Tumor Restriction and Metastasis Prevention
Ni, D., Ding, H., Liu, S., Yue, H., Bao, Y., Wang, Z., Su, Z. G., Wei, W., & Ma, G. (2015) · Small · doi:10.1002/smll.201403632 · Cited by 62
Impact of vessel maturation on antiangiogenic therapy in ovarian cancer
Lü, C., Thaker, P. H., Lin, Y. G., Spannuth, W. A., Landen, C. N., Merritt, W. M., Jennings, N. B., Langley, R. R., Gershenson, D. M., Yancopoulos, G. D., et al. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2007.12.028 · Cited by 61
Tumor-Targeted Delivery of Paclitaxel Using Low Density Lipoprotein-Mimetic Solid Lipid Nanoparticles
Kim, J., Kim, Y., Bae, K. H., Park, T. G., Lee, J. H., & Park, K. (2015) · Molecular Pharmaceutics · doi:10.1021/mp500737y · Cited by 61
Targeting and destroying tumor vasculature with a near-infrared laser-activated “nanobomb” for efficient tumor ablation
Gao, W. Z., Li, S., Liu, Z., Sun, Y., Cao, W., Tong, L., Cui, G., & Tang, B. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.05.037 · Cited by 61
Companion Diagnostic 64Cu-Liposome Positron Emission Tomography Enables Characterization of Drug Delivery to Tumors and Predicts Response to Cancer Nanomedicines
Lee, H., Gaddy, D. F., Ventura, M., Bernards, N., Souza, R. D., Kirpotin, D. B., Wickham, T. J., Fitzgerald, J. B., Zheng, J., & Hendriks, B. S. (2018) · Theranostics · doi:10.7150/thno.21670 · Cited by 61
Endothelin-1 Is a Critical Mediator of Myogenic Tone in Tumor Arterioles
Sonveaux, P., Dessy, C., Martinive, P., Havaux, X., Jordan, B. F., Gallez, B., Grégoire, V., Balligand, J., & Féron, O. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1291 · Cited by 59
Macrophage depletion through colony stimulating factor 1 receptor pathway blockade overcomes adaptive resistance to anti-VEGF therapy
Lyons, Y. A., Pradeep, S., Wu, S. Y., Haemmerle, M., Hansen, J. M., Wagner, M. J., Villar‐Prados, A., Nagaraja, A. S., Dood, R. L., Previs, R. A., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.20410 · Cited by 58
Neural Stem Cells Improve Intracranial Nanoparticle Retention and Tumor-Selective Distribution
Mooney, R., Weng, Y., Tirughana, R., Valenzuela, V., Aramburo, S., Garcia, E. P., Li, Z., Gutova, M., Annala, A. J., Berlin, J. M., et al. (2014) · Future Oncology · doi:10.2217/fon.13.217 · Cited by 57
Liposome‐Loaded Cell Backpacks
Polak, R., Lim, R. M., Beppu, M. M., Pitombo, R. N. M., Cohen, R. E., & Rubner, M. F. (2015) · Advanced Healthcare Materials · doi:10.1002/adhm.201500604 · Cited by 57
Engineered red blood cells for capturing circulating tumor cells with high performance
Zhu, D., Wu, L., Suo, M., Gao, S., Xie, W., Zan, M., Liu, A., Chen, B., Wu, W., Ji, L., et al. (2018) · Nanoscale · doi:10.1039/c7nr08032h · Cited by 57
Physalis Mottle Virus-like Nanoparticles for Targeted Cancer Imaging
Hu, H., Hema, M., Gu, Y., Zhang, Y., Yu, X., & Steinmetz, N. F. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b03956 · Cited by 57
Neutrophil-mediated transport is crucial for delivery of short-circulating magnetic nanoparticles to tumors
Naumenko, V., Nikitin, A. A., Garanina, A. S., Melnikov, P., Vodopyanov, S., Kapitanova, K., Potashnikova, D. M., Vishnevskiy, D. A., Alieva, I. B., Iliasov, A., et al. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.01.011 · Cited by 57
A gradient-loadable 64Cu-chelator for quantifying tumor deposition kinetics of nanoliposomal therapeutics by positron emission tomography
Lee, H., Zheng, J., Gaddy, D. F., Orcutt, K. D., Leonard, S. C., Geretti, E., Hesterman, J. Y., Harwell, C., Hoppin, J., Jaffray, D. A., et al. (2014) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2014.08.011 · Cited by 56
Enhancing Nanoparticle Accumulation and Retention in Desmoplastic Tumors via Vascular Disruption for Internal Radiation Therapy
Satterlee, A., Rojas, J. D., Dayton, P. A., & Huang, L. (2016) · Theranostics · doi:10.7150/thno.16681 · Cited by 56
Lung cancer targeted therapy: Folate and transferrin dual targeted, glutathione responsive nanocarriers for the delivery of cisplatin
Tan, S. H., & Wang, G. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.03.046 · Cited by 56
Precise targeting of cancer metastasis using multi-ligand nanoparticles incorporating four different ligands
Peiris, P. M., He, F., Covarrubias, G., Raghunathan, S. P., Turan, O., Lorkowski, M. E., Gnanasambandam, B., Wu, C., Schiemann, W. P., & Karathanasis, E. (2018) · Nanoscale · doi:10.1039/c8nr02513d · Cited by 56
Rationale for using TNFα and chemotherapy in regional therapy of melanoma
Lejeune, F. J., Liénard, D., Eggermont, A. M. M., Koops, H. S., Rosenkaimer, F., Gérain, J., Klaase, J. M., Kroon, B. K., Vanderveken, J., & Schmitz, P. (1994) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240560110 · Cited by 55
Use of inhibitors of the renin–angiotensin system is associated with longer survival in patients with hepatocellular carcinoma
Pinter, M., Weinmann, A., Wörns, M., Hucke, F., Bota, S. I., Marquardt, J. U., Duda, D. G., Jain, R. K., Galle, P. R., Trauner, M., et al. (2017) · United European Gastroenterology Journal · doi:10.1177/2050640617695698 · Cited by 55
Model‐Based Nanoengineered Pharmacokinetics of Iron‐Doped Copper Oxide for Nanomedical Applications
Naatz, H., Manshian, B. B., Ríos‐Luci, C., Tsikourkitoudi, V. P., Deligiannakis, Y. G., Birkenstock, J., Pokhrel, S., Mädler, L., & Soenen, S. J. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201912312 · Cited by 55
Self-citation
Role of inorganic nanoparticle degradation in cancer therapy
Maksoudian, C., Saffarzadeh, N., Hesemans, E., Dekoning, N., Buttiens, K., & Soenen, S. J. (2020) · Nanoscale Advances · doi:10.1039/d0na00286k · Cited by 55
Self-citation
Replication Study: Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs
Mantis, C., Kandela, I. K., Aird, F., & Reproducibility Project: Cancer Biology (2017) · eLife · doi:10.7554/elife.17584 · Cited by 54
A novel subset of B7-H3 + CD14 + HLA-DR −/low myeloid-derived suppressor cells are associated with progression of human NSCLC
Zhang, G., Huang, H., Zhu, Y., Yu, G., Gao, X., Xu, Y., Liu, C., Hou, J., & Zhang, X. (2015) · OncoImmunology · doi:10.4161/2162402x.2014.977164 · Cited by 53
Incidence and risk of peripheral neuropathy with nab-paclitaxel in patients with cancer: a meta-analysis
Peng, L., Bu, Z., Ye, X., Zhou, Y., & Zhao, Q. D. (2015) · European Journal of Cancer Care · doi:10.1111/ecc.12407 · Cited by 53
Tumor Stromal Disrupting Agent Enhances the Anticancer Efficacy of Docetaxel Loaded PEGylated Liposomes in Lung Cancer
Patel, K. R., Doddapaneni, R., Chowdhury, N., Boakye, C. H. A., Behl, G., & Singh, M. S. (2016) · Nanomedicine · doi:10.2217/nnm.16.37 · Cited by 53
A positron emission tomography image-guidable unimolecular micelle nanoplatform for cancer theranostic applications
Yang, J., Lu, W., Xiao, J., Zong, Q., Xu, H., Yin, Y., Hong, H., & Xu, W. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.08.036 · Cited by 51
Synthesis, characterization and theranostic evaluation of Indium-111 labeled multifunctional superparamagnetic iron oxide nanoparticles
Zolata, H., Davani, F. A., & AFARIDEH, H. (2014) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2014.09.007 · Cited by 50
The Janus Face of Tumor Microenvironment Targeted by Immunotherapy
Buoncervello, M., Gabriele, L., & Toschi, E. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20174320 · Cited by 50
Extracellular Vesicle Production Loaded with Nanoparticles and Drugs in a Trade‐off between Loading, Yield and Purity: Towards a Personalized Drug Delivery System
Piffoux, M., Silva, A., Lugagne, J., Hersen, P., Wilhelm, C., & Gazeau, F. (2017) · Advanced Biosystems · doi:10.1002/adbi.201700044 · Cited by 49
Robust, active tumor-targeting and fast bioresponsive anticancer nanotherapeutics based on natural endogenous materials
Sun, B., Deng, C., Meng, F., Zhang, J., & Zhong, Z. (2016) · Acta Biomaterialia · doi:10.1016/j.actbio.2016.08.048 · Cited by 48
Clinical scale synthesis of intrinsically radiolabeled and cyclic RGD peptide functionalized 198Au nanoparticles for targeted cancer therapy
Chakravarty, R., Chakraborty, S., Guleria, A., Kumar, C., Kunwar, A., Nair, K. V. V., Sarma, H. D., & Dash, A. K. (2019) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2019.05.005 · Cited by 48
Tumor targeting and imaging with dual-peptide conjugated multifunctional liposomal nanoparticles
Rangger, Helbok, A., Kremser, C., Koehler, G., Prassl, R., Andreae, F., Virgolini, I. J., von Guggenberg, E., Decristoforo, C., & Sosabowski, J. K. (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s51927 · Cited by 47
Stem cell-mediated delivery of SPIO-loaded gold nanoparticles for the theranosis of liver injury and hepatocellular carcinoma
Zhao, J., Vykoukal, J. V., Abdelsalam, M. E., Recio‐Boiles, A., Huang, Q., Qiao, Y., Singhana, B., Wallace, M. J., Avritscher, R., & Melancon, M. P. (2014) · Nanotechnology · doi:10.1088/0957-4484/25/40/405101 · Cited by 47
Tumor vessel stabilization and remodeling by anti-angiogenic therapy with bevacizumab
Weißhardt, P., Trarbach, T., Dürig, J., Paul, A., Reis, H., Tilki, D., Miroschnik, I., Ergün, S., & Klein, D. (2011) · Histochemistry and Cell Biology · doi:10.1007/s00418-011-0898-8 · Cited by 46
In Silico Design of Optimal Dissolution Kinetics of Fe‐Doped ZnO Nanoparticles Results in Cancer‐Specific Toxicity in a Preclinical Rodent Model
Manshian, B. B., Pokhrel, S., Himmelreich, U., Tämm, K., Sikk, L., Fernández, A., Ralló, R., Tamm, T., Mädler, L., & Soenen, S. J. (2017) · Advanced Healthcare Materials · doi:10.1002/adhm.201601379 · Cited by 46
Self-citation
Biological evaluation of RGDfK-gold nanorod conjugates for prostate cancer treatment
Gormley, A. J., Malugin, A., Ray, A., Robinson, R., & Ghandehari, H. (2011) · Journal of drug targeting · doi:10.3109/1061186x.2011.623701 · Cited by 45
PLGA Based Nanoparticles for the Monocyte-Mediated Anti-Tumor Drug Delivery System
Allavena, P., Palmioli, A., Avigni, R., Sironi, M., Ferla, B. L., & Maeda, A. (2020) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2020.2881 · Cited by 45
Poly(3‐hydroxybutyrate‐co‐R‐3‐hydroxyhexanoate) Nanoparticles with Polyethylenimine Coat as Simple, Safe, and Versatile Vehicles for Cell Targeting: Population Characteristics, Cell Uptake, and Intracellular Trafficking
Wu, L., Wang, D., Parhamifar, L., Hall, A., Chen, G., & Moghimi, S. M. (2014) · Advanced Healthcare Materials · doi:10.1002/adhm.201300533 · Cited by 44
Fibrin degradation by rtPA enhances the delivery of nanotherapeutics to A549 tumors in nude mice
Zhang, B., Jiang, T., She, X., Shen, S., Wang, S., Deng, J., Shi, W., Mei, H., Hu, Y., Pang, Z., et al. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.04.015 · Cited by 44
Recent advances in tumor microenvironment associated therapeutic strategies and evaluation models
Haider, T., Sandha, K. K., Soni, V., & Gupta, P. N. (2020) · Materials Science and Engineering C · doi:10.1016/j.msec.2020.111229 · Cited by 44
Multimodality Nuclear and Fluorescence Tumor Imaging in Mice Using a Streptavidin Nanoparticle
Liang, M., Liu, X., Cheng, D., Liu, G., Dou, S., Wang, Y., Rusckowski, M., & Hnatowich, D. J. (2010) · Bioconjugate Chemistry · doi:10.1021/bc100081h · Cited by 43
Orientation‐Specific Attachment of Polymeric Microtubes on Cell Surfaces
Gilbert, J. B., O'Brien, J. S., Suresh, H., Cohen, R. E., & Rubner, M. F. (2013) · Advanced Materials · doi:10.1002/adma.201302673 · Cited by 43
Reply to “Evaluation of nanomedicines: stick to the basics”
Wilhelm, S., Tavares, A. J., & Chan, W. C. W. (2016) · Nature Reviews Materials · doi:10.1038/natrevmats.2016.74 · Cited by 43
Doxorubicin-loaded dendritic-Fe3O4 supramolecular nanoparticles for magnetic drug targeting and tumor regression in spheroid murine melanoma model
Nigam, S., & Bahadur, D. (2018) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2018.01.005 · Cited by 43
Selective uptake of chitosan polymeric micelles by circulating monocytes for enhanced tumor targeting
Yang, X., Lian, K., Tan, Y., Zhu, Y., Liu, X., Zeng, Y., Yu, T., Meng, T., Yuan, H., & Hu, F. (2019) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2019.115435 · Cited by 43
Self-Propelled Gemini-like LMWH-Scaffold Nanodrugs for Overall Tumor Microenvironment Manipulation via Macrophage Reprogramming and Vessel Normalization
Xu, C., Yang, S., Jiang, Z., Zhou, J., & Yao, J. (2019) · Nano Letters · doi:10.1021/acs.nanolett.9b04024 · Cited by 43
Captopril improves tumor nanomedicine delivery by increasing tumor blood perfusion and enlarging endothelial gaps in tumor blood vessels
Zhang, B., Jiang, T., Tuo, Y., Jin, K., Luo, Z., Shi, W., Mei, H., Hu, Y., Pang, Z., & Jiang, X. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.09.007 · Cited by 41
Development of a real time imaging-based guidance system of magnetic nanoparticles for targeted drug delivery
Zhang, X., Le, T., & Yoon, J. (2016) · Journal of Magnetism and Magnetic Materials · doi:10.1016/j.jmmm.2016.10.056 · Cited by 40
In vivooptical imaging using quantum dots for the management of brain tumors
Popescu, M. A., & Toms, S. A. (2006) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.6.6.879 · Cited by 39
Influence of formulation variables on the biodistribution of multifunctional block copolymer micelles
Fonge, H., Huang, H., Scollard, D. A., Reilly, R. M., & Allen, C. J. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.09.088 · Cited by 39
Surface engineered nanostructured lipid carriers for targeting MDR tumor: Part II. In vivo biodistribution, pharmacodynamic and hematological toxicity studies
Negi, L. M. S., Talegaonkar, S., Jaggi, M., Verma, A. K., Verma, R., Dobhal, S., & Kumar, V. (2014) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2014.09.061 · Cited by 37
iRGD-functionalized PEGylated Nanoparticles for Enhanced Colon Tumor Accumulation and Targeted Drug Delivery
Ma, L., Chen, Q., Ma, P., Han, M. K., Xu, Z., Kang, Y., Xiao, B., & Merlin, D. (2017) · Nanomedicine · doi:10.2217/nnm-2017-0107 · Cited by 37
Integrin αvβ3-Targeted [64Cu]CuS Nanoparticles for PET/CT Imaging and Photothermal Ablation Therapy
Cui, L., Xiong, C., Zhou, M., Shi, S., Chow, D. S., & Li, C. (2018) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.8b00690 · Cited by 37
99mTc-labelled nanosystem as tumour imaging agent for SPECT and SPECT/CT modalities
Polyák, A., Hajdu, I., Bodnár, M., Trencsényi, G., Pöstényi, Z., Haász, V., Jánoki, G., Jánoki, G. A., Balogh, L. P., & Borbely, J. D. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.03.049 · Cited by 36
Evaluation of a PSMA-targeted BNF nanoparticle construct
Azad, B. B., Banerjee, S. R., Pullambhatla, M., Lacerda, S. H. D. P., Foss, C. A., Wang, Y., Ivkov, R., & Pomper, M. G. (2015) · Nanoscale · doi:10.1039/c4nr06069e · Cited by 36
Tumour vessel normalization takes centre stage
Cully, M. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.4 · Cited by 36
Effective tumor targeting and enhanced anti-tumor effect of liposomes engrafted with peptides specific for tumor lymphatics and vasculature
Herringson, T. P., & Altin, J. G. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.03.044 · Cited by 35
Subtumoral analysis of PRINT nanoparticle distribution reveals targeting variation based on cellular and particle properties
Roode, L. E., Brighton, H. E., Bo, T., Perry, J. L., Parrott, M. C., Kersey, F. R., Luft, J. C., Bear, J. E., DeSimone, J. M., & Davis, I. J. (2016) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2015.12.382 · Cited by 34
Dual-ligand α5β1 and α6β4 integrin targeting enhances gene delivery and selectivity to cancer cells
Levine, R. M., & Kokkoli, E. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.02.017 · Cited by 33
Magnetic drug targeting in a rhabdomyosarcoma rat model using magnetite-dextran composite nanoparticle-bound mitoxantrone and 0.6 tesla extracorporeal magnets − sarcoma treatment in progress
Krukemeyer, M. G., Krenn, V., Jakobs, M., & Wagner, W. (2011) · Journal of drug targeting · doi:10.3109/1061186x.2011.622399 · Cited by 32
Fabrication and evaluation of tumor-targeted positive MRI contrast agent based on ultrasmall MnO nanoparticles
Huang, H., Yue, T., Xu, K., Golzarian, J., Yu, J., & Huang, J. T. (2015) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2015.04.047 · Cited by 30
Quantitative Comparison of Tumor Delivery for Multiple Targeted Nanoparticles Simultaneously by Multiplex ICP-MS
Elias, A., Crayton, S. H., Warden‐Rothman, R., & Tsourkas, A. (2014) · Scientific Reports · doi:10.1038/srep05840 · Cited by 30
High content analysis at single cell level identifies different cellular responses dependent on nanomaterial concentrations
Manshian, B. B., Munck, S., Agostinis, P., Himmelreich, U., & Soenen, S. J. (2015) · Scientific Reports · doi:10.1038/srep13890 · Cited by 30
Self-citation
Nanoparticle-induced inflammation can increase tumor malignancy
Manshian, B. B., Poelmans, J., Saini, S., Pokhrel, S., Grez, J. J., Himmelreich, U., Mädler, L., & Soenen, S. J. (2017) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.12.020 · Cited by 30
Self-citation
Nanoparticles Induce Apoptosis Via Mediating Diverse Cellular Pathways
Chen, L., Wu, L., & Yang, W. (2018) · Nanomedicine · doi:10.2217/nnm-2018-0167 · Cited by 30
Mono-dispersed high magnetic resonance sensitive magnetite nanocluster probe for detection of nascent tumors by magnetic resonance molecular imaging
Zhang, C., Xie, X., Liang, S., Li, M., Liu, Y., & Gu, H. (2011) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2011.11.013 · Cited by 29
Rational Design of GO-Modified Fe3O4/SiO2 Nanoparticles with Combined Rhenium-188 and Gambogic Acid for Magnetic Target Therapy
Yang, Y., Liu, Y., Cheng, C., Shi, H., Yang, H., Yuan, H., & Ni, C. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b07589 · Cited by 29
A comparison between acoustic properties and heat effects in biogenic (magnetosomes) and abiotic magnetite nanoparticle suspensions
Józefczak, A., Leszczyński, B., Skumiel, A., & Hornowski, T. (2016) · Journal of Magnetism and Magnetic Materials · doi:10.1016/j.jmmm.2016.01.054 · Cited by 28
iRGD-Mediated and Enzyme-Induced Precise Targeting and Retention of Gold Nanoparticles for the Enhanced Imaging and Treatment of Breast Cancer
Yang, Y., Chen, Q., Li, S., Ma, W., Yao, G., Ren, F., Cai, Z., Zhao, P., Liao, G., Xiong, J., et al. (2018) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2018.2592 · Cited by 28
Evaluation of Folate Conjugated Superparamagnetic Iron Oxide Nanoparticles for Scintigraphic/Magnetic Resonance Imaging
Chauhan, R. P., Mathur, R., Singh, G., Kaul, A., Bag, N., Singh, S., Kumar, H., Patra, M. K., & Mishra, A. K. (2013) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2013.1548 · Cited by 25
Access granted: iRGD helps silicasome-encased drugs breach the tumor barrier
Ruoslahti, E. I. (2017) · Journal of Clinical Investigation · doi:10.1172/jci93955 · Cited by 25
A Multiparametric Evaluation of Quantum Dot Size and Surface-Grafted Peptide Density on Cellular Uptake and Cytotoxicity
Maksoudian, C., Soenen, S. J., Susumu, K., Oh, E., Medintz, I. L., & Manshian, B. B. (2020) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.0c00078 · Cited by 25
Self-citation
Antitumor Effect of Nanoparticle 131 I-Labeled Arginine-Glycine-Aspartate–Bovine Serum Albumin–Polycaprolactone in Lung Cancer
Ming, H., Fang, L., Jingmei, G., Li, C., Ji, Y., Shen, Y., Hu, Y., Li, N., Chang, J. K., Li, W., et al. (2017) · American Journal of Roentgenology · doi:10.2214/ajr.16.16947 · Cited by 24
Tumor-Penetrating Delivery of siRNA against TNFα to Human Vestibular Schwannomas
Ren, Y., Sagers, J. E., Landegger, L. D., Bhatia, S. N., & Stanković, K. M. (2017) · Scientific Reports · doi:10.1038/s41598-017-13032-9 · Cited by 23
Rapid chelator-free radiolabeling of quantum dots for in vivo imaging
Tang, T., Wei, Y., Yang, Q., Yang, Y., Sailor, M. J., & Pang, H. (2019) · Nanoscale · doi:10.1039/c9nr08508d · Cited by 23
Decreasing Systemic Toxicity Via Transdermal Delivery of Anticancer Drugs
Fang, J., Liu, P., & Huang, C. (2008) · Current Drug Metabolism · doi:10.2174/138920008785821693 · Cited by 22
Targeting of drug-loaded nanoparticles to tumor sites increases cell death and release of danger signals
Alev, M., Egenberger, L., Mühleisen, L., Weigel, B., Frey, B., Friedrich, R. P., Pöttler, M., Alexiou, C., & Janko, C. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.07.007 · Cited by 22
A sequentially responsive and structure-transformable nanoparticle with a comprehensively improved ‘CAPIR cascade’ for enhanced antitumor effect
Xu, C., Sun, Y., Yu, Y., Hu, M. Y., Yang, C., & Zhang, Z. (2018) · Nanoscale · doi:10.1039/c8nr08781d · Cited by 22
Folate-Targeted Gadolinium-Lipid-Based Nanoparticles as a Bimodal Contrast Agent for Tumor Fluorescent and Magnetic Resonance Imaging
Nakamura, T., Kawano, K., Shiraishi, K., Yokoyama, M., & Maitani, Y. (2014) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b13-00484 · Cited by 21
Neural stem cells promote glioblastoma formation in nude mice
Wang, J., Liu, J., Meng, H., Guan, Y., Yin, Y., Zhao, Z., Sun, G., Wu, A., Chen, L., & Yu, X. (2019) · Clinical & Translational Oncology · doi:10.1007/s12094-019-02087-x · Cited by 21
Real-time monitoring of magnetic drug targeting using fibered confocal fluorescence microscopy
Bai, J., Wang, J. T.-W., Mei, K., Al-Jamal, W. T., & Al‐Jamal, K. T. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.07.026 · Cited by 20
Systemic tumor‐targeted sodium iodide symporter (NIS) gene therapy of hepatocellular carcinoma mediated by B6 peptide polyplexes
Urnauer, S., Klutz, K., Grünwald, G. K., Morys, S., Schwenk, N., Zach, C., Gildehaus, F., Rödl, W., Ogris, M., Wagner, E., et al. (2017) · The Journal of Gene Medicine · doi:10.1002/jgm.2957 · Cited by 20
Comparison of the ${^{1}{\rm H}}$ NMR Relaxation Enhancement Produced by Bacterial Magnetosomes and Synthetic Iron Oxide Nanoparticles for Potential Use as MR Molecular Probes
Hu, L. L., Zhang, F., Wang, Z., You, X. F., Nie, L., Wang, H. X., Song, T., & Yang, W. H. (2010) · IEEE Transactions on Applied Superconductivity · doi:10.1109/tasc.2010.2041218 · Cited by 18
Evaluation of cytotoxic and tumor targeting capability of 177Lu-DOTATATE-nanoparticles: a trailblazing strategy in peptide receptor radionuclide therapy
Arora, G., Dubey, P., Shukla, J., Ghosh, S., & Bandopadhyaya, G. P. (2016) · Annals of Nuclear Medicine · doi:10.1007/s12149-016-1067-x · Cited by 18
Synthesis of liver-targeting dual-ligand modified GCGA/5-FU nanoparticles and their characteristics in vitro and in vivo
He, B., Cheng, M., Gao, X., Wang, Y., Chen, H., Li, Y., Han, J., & Zhang, Z. (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s52877 · Cited by 17
Establishment of a biophysical model to optimize endoscopic targeting of magnetic nanoparticles for cancer treatment
Roeth, A. A., Slabu, I., Baumann, M., Alizai, P. H., Schmeding, M., Guntherodt, G., Schmitz‐Rode, T., & Neumann, U. P. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s132162 · Cited by 17
Synthesis, Positron Emission Tomography Imaging, and Therapy of Diabody Targeted Drug Lipid Nanoparticles in a Prostate Cancer Murine Model
Wong, P. W., Li, L., Chea, J., Delgado, M. K., Poku, E. K., Szpikowska, B. K., Bowles, N., Minnix, M., Colcher, D. M., Wong, J. Y. C., et al. (2017) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2017.2253 · Cited by 15
Transferrin- and folate-modified, double-targeted nanocarriers for gene delivery
Jing, F., Li, D., Xu, W., Liu, Y., Wang, K., & Sui, Z. (2013) · Pharmaceutical Biology · doi:10.3109/13880209.2013.853812 · Cited by 13
Theranostic Iron Oxide Nanoparticle Cargo Defines Extracellular Vesicle‐Dependent Modulation of Macrophage Activation and Migratory Behavior
Mulens‐Arias, V., Nicolás‐Boluda, A., Silva, A., & Gazeau, F. (2018) · Advanced Biosystems · doi:10.1002/adbi.201800079 · Cited by 13
Erythrocyte-Membrane-Camouflaged Nanocarriers with Tunable Paclitaxel Release Kinetics via Macromolecular Stereocomplexation
Lin, Y., Elsabahy, M., Khan, S. A., Zhang, F., Song, Y. H., Dong, M., Li, R., Smolen, J. A., Letteri, R. A., Su, L., et al. (2020) · ACS Materials Letters · doi:10.1021/acsmaterialslett.0c00044 · Cited by 12
Evaluation of biotinylated magnetic nanoparticles for tumour imaging
Chauhan, R. P., Mathur, R., Singh, G., Bag, N., Singh, S., Chuttani, K., Kumar, B. S. H., Agrawal, S. K., & Mishra, A. K. (2013) · Journal of Materials Science · doi:10.1007/s10853-013-7193-0 · Cited by 7
Opening the vascular gate
Malinova, T. S., & Huveneers, S. (2019) · Nature Nanotechnology · doi:10.1038/s41565-019-0372-7 · Cited by 4
Untitled work
(2007) · PubMed

Research works printed but not linked: 1

de Wolf, 2007, Effect of Cationic Carriers on the Pharmacokinetics and Tumor Localization of Nucleic Acids after Intravenous Administration, Int. J. Pharm., 331, 167, 10.1016/j.ijpharm.2006.10.029 · DOI

Sorted by citations

Current advance of nanotechnology in diagnosis and treatment for malignant tumors
Wang, B., Hu, S., Teng, Y., Chen, J., Wang, H., Xu, Y., Wang, K., Xu, J., Cheng, Y., & Gao, X. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01889-y · Cited by 641
Triple Negative Breast Cancer Treatment Options and Limitations: Future Outlook
Obidiro, O. P., Battogtokh, G., & Akala, E. O. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15071796 · Cited by 564
The tumor EPR effect for cancer drug delivery: Current status, limitations, and alternatives
Sun, R., Xiang, J., Zhou, Q., Piao, Y., Tang, J., Shao, S., Zhou, Z., Bae, Y. H., & Shen, Y. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114614 · Cited by 474
Stimuli-Responsive Polymer-Based Nanosystems for Cancer Theranostics
Wei, D., Sun, Y., Zhu, H., & Fu, Q. (2023) · ACS Nano · doi:10.1021/acsnano.3c06019 · Cited by 326
Cancer nanotechnology: current status and perspectives
Kemp, J. A., & Kwon, Y. J. (2021) · Nano Convergence · doi:10.1186/s40580-021-00282-7 · Cited by 290

See all 512

Authors: Izci, M., Maksoudian, C., Manshian, B. B., & Soenen, S. J.
Affiliations: KU Leuven (BE)
Corresponding author: Soenen, Stefaan J.
ORCID: Maksoudian, Christy
Manshian, Bella B.
Soenen, Stefaan J.
Venue: Chemical Reviews
Publisher: American Chemical Society (ACS)
Published: 2021-01-14
Volume: 121
Issue: 3
Pages: 1746-1803
ISSN: 0009-2665 (ISSN-L)
1520-6890
DOI: 10.1021/acs.chemrev.0c00779
PMC: PMC7883342
OpenAlex: W3118474372
Cited by: 506
References: 529
Citations by year: 2026: 81 · 2025: 91 · 2024: 109 · 2023: 96 · 2022: 94 · 2021: 35
FWCI: 5.77
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by-nc-nd
pubs.acs.org/page/policy/authorchoice_ccbyncnd_termsofuse.html (vor)
Locations: Chemical Reviews (publishedVersion, cc-by-nc-nd)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Lirias (submittedVersion, other-oa)
Funders: H2020 European Research Council (757398)
Fonds Wetenschappelijk Onderzoek (G0B2919N)
Bijzonder Onderzoeksfonds (3M180306)
Topics: Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
Physical Sciences › Materials Science › Polymers and Plastics › Dendrimers and Hyperbranched Polymers
Keywords: nanoparticle delivery, solid tumors, enhanced permeability and retention effect, tumor vasculature, active targeting, passive targeting, tumor endothelium
MeSH terms: Animals, Humans, Neoplasms, Peptides, Drug Delivery Systems, Nanoparticles, Tumor Microenvironment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The Use of Alternative Strategies for Enhanced Nanoparticle Delivery to Solid Tumors

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks